JP2013515004A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013515004A5 JP2013515004A5 JP2012544920A JP2012544920A JP2013515004A5 JP 2013515004 A5 JP2013515004 A5 JP 2013515004A5 JP 2012544920 A JP2012544920 A JP 2012544920A JP 2012544920 A JP2012544920 A JP 2012544920A JP 2013515004 A5 JP2013515004 A5 JP 2013515004A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- group
- agent
- composition
- gelatin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28798809P | 2009-12-18 | 2009-12-18 | |
| US61/287,988 | 2009-12-18 | ||
| PCT/US2010/061135 WO2011075691A1 (en) | 2009-12-18 | 2010-12-17 | Methods and compositions for stable liquid drug formulations |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015201055A Division JP2016053038A (ja) | 2009-12-18 | 2015-10-09 | 安定な液体薬剤のための方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013515004A JP2013515004A (ja) | 2013-05-02 |
| JP2013515004A5 true JP2013515004A5 (enExample) | 2014-02-06 |
Family
ID=44167729
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012544920A Pending JP2013515004A (ja) | 2009-12-18 | 2010-12-17 | 安定な液体薬剤のための方法および組成物 |
| JP2015201055A Pending JP2016053038A (ja) | 2009-12-18 | 2015-10-09 | 安定な液体薬剤のための方法および組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015201055A Pending JP2016053038A (ja) | 2009-12-18 | 2015-10-09 | 安定な液体薬剤のための方法および組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US9629920B2 (enExample) |
| EP (1) | EP2512460A4 (enExample) |
| JP (2) | JP2013515004A (enExample) |
| CN (1) | CN102802617B (enExample) |
| AU (1) | AU2010330750B2 (enExample) |
| BR (1) | BR112012014962A2 (enExample) |
| CA (1) | CA2784826A1 (enExample) |
| IL (1) | IL220465A (enExample) |
| RU (1) | RU2589697C2 (enExample) |
| WO (1) | WO2011075691A1 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013204801B2 (en) | 2012-05-23 | 2014-11-06 | Omniblend Innovation Pty Ltd | Composition and method for management of diabetes or pre-diabetes |
| JP6223444B2 (ja) * | 2012-07-05 | 2017-11-01 | ザ リサーチ ファウンデイション フォー ザ ステイト ユニバーシティー オブ ニューヨーク | 蛋白質‐脂質複合体を用いた抗生物質治療の増強 |
| CN113384373B (zh) * | 2013-11-05 | 2022-10-21 | 辛纳吉勒公司 | 经由口腔进行连续药物递送的装置和方法 |
| PT2838510T (pt) | 2013-11-08 | 2016-11-23 | Lilly Co Eli | Solução de atomoxetina |
| WO2016089893A1 (en) | 2014-12-01 | 2016-06-09 | Achelios Therapeutics Inc. | Methods and compositions for treating migraine and conditions associated with pain |
| CN113197851A (zh) | 2015-05-06 | 2021-08-03 | 辛纳吉勒公司 | 包含药物粒子的药用悬浮液、用于其配给的装置、以及其使用方法 |
| KR20250047404A (ko) * | 2015-12-08 | 2025-04-03 | 바이오매트리카 인코포레이티드 | 적혈구 침강 속도의 감소 |
| CN106199007B (zh) * | 2016-08-03 | 2017-04-05 | 烟台普罗吉生物科技发展有限公司 | 蛋白保护剂 |
| CN115813888A (zh) | 2016-12-20 | 2023-03-21 | 罗曼治疗系统股份公司 | 包含阿塞那平的透皮治疗系统 |
| EP3558276B1 (en) | 2016-12-20 | 2024-11-06 | LTS Lohmann Therapie-Systeme AG | Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene |
| WO2019002204A1 (en) | 2017-06-26 | 2019-01-03 | Lts Lohmann Therapie-Systeme Ag | TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE AND SILICONE-TYPE ACRYLIC HYBRID POLYMER |
| WO2019038584A1 (en) * | 2017-08-19 | 2019-02-28 | Ftf Pharma Private Limited | An oral pharmaceutical composition comprising zonisamide and process of preparation thereof |
| AU2018333058A1 (en) * | 2017-09-15 | 2020-03-12 | Gojo Industries, Inc. | Antimicrobial composition |
| AU2019291060B2 (en) | 2018-06-20 | 2024-09-05 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine |
| US12329862B2 (en) | 2018-06-20 | 2025-06-17 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine |
| CN109212176B (zh) * | 2018-08-30 | 2019-10-11 | 中拓生物有限公司 | 一种丙酮酸测定试剂盒及其制备方法和应用 |
| JP7653352B2 (ja) * | 2018-09-05 | 2025-03-28 | エクスプレステック、リミテッド、ライアビリティ、カンパニー | 免疫グロブリンａ製剤 |
| US11413275B1 (en) | 2018-12-14 | 2022-08-16 | ECI Pharmaceuticals, LLC | Oral liquid compositions including valsartan |
| US10478422B1 (en) | 2018-12-14 | 2019-11-19 | ECI Pharmaceuticals, LLC | Oral liquid compositions including valsartan |
| US11446243B1 (en) * | 2019-08-05 | 2022-09-20 | ECI Pharmaceuticals, LLC | Oral liquid compositions including valsartan |
| WO2022103639A1 (en) | 2020-11-16 | 2022-05-19 | Orcosa Inc. | Methods of treating autoimmune or inflammatory conditions with cannabidiol or its derivatives/analogs |
| US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
| US11452690B1 (en) | 2021-01-27 | 2022-09-27 | ECI Pharmaceuticals, LLC | Oral liquid compositions comprising amlodipine besylate and methods of using the same |
| CN113384526A (zh) * | 2021-08-03 | 2021-09-14 | 合肥医工医药股份有限公司 | 一种稳定的阿哌沙班口服溶液制剂及其制备方法 |
| CN117398380A (zh) * | 2022-06-29 | 2024-01-16 | 威智医药股份有限公司 | 卡维地洛或其盐、组合物的新用途及该组合物和制备方法 |
| WO2025068937A1 (en) * | 2023-09-30 | 2025-04-03 | Liqmeds Worldwide Limited | An oral liquid formulation of metoprolol |
| AU2024352372A1 (en) * | 2023-09-30 | 2026-04-09 | Liqmeds Worldwide Limited | An oral liquid formulation of metoprolol |
| CN119112774A (zh) * | 2024-09-23 | 2024-12-13 | 石家庄四药有限公司 | 一种利奈唑胺氯化钠注射液及其制备方法 |
| US12605388B2 (en) | 2024-09-25 | 2026-04-21 | Azurity Pharmaceuticals Ireland Limited | Lamotrigine salts, co-crystals, and compositions |
| CN120000598B (zh) * | 2025-03-27 | 2025-10-10 | 广东立国制药有限公司 | 一种头孢呋辛酯直压颗粒及其制备工艺 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61271226A (ja) * | 1985-05-24 | 1986-12-01 | Chemo Sero Therapeut Res Inst | 利尿剤 |
| JPS63215640A (ja) * | 1987-03-04 | 1988-09-08 | Nippon Hai Potsukusu:Kk | 易吸収性抗炎症剤及びその製造方法 |
| US5051406A (en) * | 1987-03-04 | 1991-09-24 | Nippon Hypox Laboratories Incorporated | Pharmaceutical composition using albumin as a carrier and process for producing the same |
| JPH05238947A (ja) * | 1992-02-28 | 1993-09-17 | Yakult Honsha Co Ltd | 細菌毒素中和剤 |
| ATE236657T1 (de) | 1997-05-09 | 2003-04-15 | Deutsches Krebsforsch | Konjugat, umfassend einen folsäureantagonisten und einen träger |
| PT1023050E (pt) | 1997-06-27 | 2013-12-04 | Abraxis Bioscience Llc | Novas formulações de agentes farmacológicos, métodos para a sua preparação e métodos para a sua utilização |
| HUP9701554D0 (en) | 1997-09-18 | 1997-11-28 | Human Oltoanyagtermeloe Gyogys | Pharmaceutical composition containing plazma proteins |
| JPH11258236A (ja) * | 1998-03-09 | 1999-09-24 | Sekisui Chem Co Ltd | 抗リン脂質抗体測定試薬 |
| CA2362338A1 (en) * | 1998-07-30 | 2000-02-10 | Human Rt. | Pharmaceutically acceptable composition comprising an aqueous solution of paclitaxel and albumin |
| PL197812B1 (pl) | 1999-07-09 | 2008-04-30 | Ortho Mcneil Pharm Inc | Doustne ciekłe kompozycje farmaceutyczne maskujące smak |
| CA2509365C (en) | 2002-12-09 | 2012-08-07 | American Bioscience, Inc. | Compositions and methods of delivery of pharmacological agents |
| ES2383300T3 (es) | 2003-11-13 | 2012-06-20 | Hanmi Holdings Co., Ltd | Fragmento Fc de IgG para un vehículo de fármacos y procedimiento para su preparación |
| US20050266031A1 (en) | 2004-05-25 | 2005-12-01 | Jay Dickerson | Pharmaceutical suspension composition |
| TW200607523A (en) | 2004-06-01 | 2006-03-01 | Domantis Ltd | Drug compositions, fusions and conjugates |
| DE102004057196A1 (de) | 2004-11-26 | 2006-06-01 | Rösner Research GmbH & Co.KG | Verfahren zur Herstellung von Albumin-Konjugaten mit Nicht-steroidalen Antirheumatika (NSAR) |
| EA015277B1 (ru) | 2008-04-22 | 2011-06-30 | Государственное Научное Учреждение "Институт Биоорганической Химии Национальной Академии Наук Беларуси" | Конъюгат 28-норбрассинолида с бычьим сывороточным альбумином в качестве иммуногена |
| US20130109674A1 (en) | 2009-12-18 | 2013-05-02 | Achelios Therapeutics Llc | Methods and compositions for treating and preventing trigeminal autonomic cephalgias, migraine, and vascular conditions |
| JP5944325B2 (ja) | 2009-12-18 | 2016-07-05 | エクソドス ライフ サイエンシーズ リミテッド パートナーシップ | 皮膚の炎症を治療するための方法及び組成物 |
| CA2784788A1 (en) | 2009-12-18 | 2011-06-23 | Exodos Life Sciences Limited Partnership | Methods and compositions for treating peripheral vascular disease |
-
2010
- 2010-12-17 WO PCT/US2010/061135 patent/WO2011075691A1/en not_active Ceased
- 2010-12-17 AU AU2010330750A patent/AU2010330750B2/en not_active Ceased
- 2010-12-17 CN CN201080064175.9A patent/CN102802617B/zh not_active Expired - Fee Related
- 2010-12-17 EP EP10838322.5A patent/EP2512460A4/en not_active Withdrawn
- 2010-12-17 JP JP2012544920A patent/JP2013515004A/ja active Pending
- 2010-12-17 US US13/517,024 patent/US9629920B2/en not_active Expired - Fee Related
- 2010-12-17 BR BR112012014962A patent/BR112012014962A2/pt not_active IP Right Cessation
- 2010-12-17 RU RU2012130391/15A patent/RU2589697C2/ru not_active IP Right Cessation
- 2010-12-17 CA CA2784826A patent/CA2784826A1/en not_active Abandoned
-
2012
- 2012-06-17 IL IL220465A patent/IL220465A/en not_active IP Right Cessation
-
2015
- 2015-10-09 JP JP2015201055A patent/JP2016053038A/ja active Pending
-
2017
- 2017-04-24 US US15/495,330 patent/US20170224834A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013515004A5 (enExample) | ||
| RU2012130391A (ru) | Способы получения стабильных жидких лекарственных препаратов и их композиции | |
| CA2717605A1 (en) | Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection | |
| JP6238991B2 (ja) | 局所ケトプロフェン組成物 | |
| RU2013117209A (ru) | Буферные глазные композиции и способы их применения | |
| JP2022551730A (ja) | カンナビジオールの経皮送達 | |
| Deng et al. | Improving the growth performance and cholesterol metabolism of rainbow trout (Oncorhynchus mykiss) fed soyabean meal-based diets using dietary cholesterol supplementation | |
| CN103237550A (zh) | 含有糠酸莫米松及盐酸氮卓斯汀的鼻内给药用药物组合物 | |
| TW201330873A (zh) | 口服溶液 | |
| EA200601724A1 (ru) | Новые композиции для местной доставки | |
| WO2007117581A3 (en) | Stabilized transdermal bupropion preparations | |
| CN103053529B (zh) | 香芹酚和氟啶胺的农药组合物 | |
| JP2006528990A5 (enExample) | ||
| US20090246273A1 (en) | Ketorolac Sublingual Spray for the Treatment of Pain | |
| CN101658170B (zh) | 一种用于混凝土所使用的聚羧酸减水剂的防腐剂 | |
| JP2011074032A (ja) | 外用医薬組成物 | |
| US6777448B2 (en) | Veterinary compositions for the treatment of parasitic diseases | |
| JPWO2017073798A1 (ja) | 鼻粘膜投与用医薬組成物 | |
| JPH05271053A (ja) | 安定な点眼剤 | |
| WO2005101982A2 (en) | A stable ophthalmic composition | |
| CN108143713A (zh) | 一种增加羟喜树碱溶解度的方法 | |
| JP2008528572A5 (enExample) | ||
| Kilic et al. | Intestinal absorption of digoxin and interaction with nimodipine in rats | |
| KR101894891B1 (ko) | 흡수가 증가된 덱시부프로펜 에멀젼 함유 겔 제형 | |
| CN103271873B (zh) | 一种兽用泰妙菌素混悬注射液及其制备方法 |